EP2040713
Gallsýruafleiður sem FXR-tenglar fyrir fyrirbygginguna eða meðhöndlunina á FXR-miðluðum sjúkdómum eða kvillum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
27.6.2007EP published:
18.6.2014EP application number:
07809913.2
EP translation filed:
11.9.2014Grant published:
15.10.2014EPO information:
European Patent Register
Max expiry date:
26.6.2027Expiry date:
26.6.2022
Title:
BILE ACID DERIVATIVES AS FXR LIGANDS FOR THE PREVENTION OR TREATMENT OF FXR-MEDIATED DESEASES OR CONDITIONS
Timeline
Today
27.6.2007EP application
18.6.2014EP Publication
11.9.2014Translation submitted
15.10.2014Registration published
26.6.2022Expires
Owner
Name:
Intercept Pharmaceuticals Inc.Address:
421 Hudson Street, Suite 212, 10014, New York, NY, US
Inventor
Name:
PELLICCIARI, RobertoAddress:
Perugia, IT
Name:
FIORUCCI, StefanoAddress:
Perugia, IT
Name:
PRUZANSKI, MarkAddress:
New York, NY, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
816635 PDate:
27.6.2006Country:
US
Classification
Categories:
C07J 9/00, A61K 31/575, C07J 31/00, A61P 1/16
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 10.9.2014
Expires: 26.6.2015
Payer: Árnason Faktor
Number: 9
Paid: 7.5.2015
Expires: 26.6.2016
Payer: Árnason Faktor
Number: 10
Paid: 1.6.2016
Expires: 26.6.2017
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 31.5.2017
Expires: 26.6.2018
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 31.5.2018
Expires: 26.6.2019
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 31.5.2019
Expires: 26.6.2020
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 2.6.2020
Expires: 26.6.2021
Payer: Sigurjónsson & Thor ehf.
Number: 15
Paid: 2.6.2021
Expires: 26.6.2022
Payer: Sigurjónsson & Thor ehf.